A Pragmatic Randomized Trial Comparing Surgical Clipping and Endovascular Treatment of Unruptured Intracranial Aneurysms

医学 剪裁(形态学) 随机对照试验 外科 致盲 动脉瘤 血管内治疗 入射(几何) 闭塞 栓塞 血管内卷取 哲学 语言学 物理 光学
作者
Tim E. Darsaut,J. Max Findlay,Michel W. Bojanowski,Chiraz Chaalala,Daniela Iancu,Daniel Roy,Alain Weill,William Boisseau,Ange Diouf,Elsa Magro,Marc Kotowski,Michael B. Keough,Laurent Estrade,Nicolas Bricout,J.-P. Lejeune,Michael Chow,Cian O’Kelly,Jeremy Rempel,Robert Ashforth,Howard J. Lesiuk,John Sinclair,Undrakh-Erdene Erdenebold,John H. Wong,Félix Scholtes,Didier Martin,Bernard Otto,Alain Bilocq,Eric Truffer,Ken Butcher,Allan J. Fox,Adam S Arthur,Laurent Létourneau-Guillon,F Guilbert,Miguel Chagnon,Justine Zehr,Behzad Farzin,Guylaine Gevry,Jean Raymond
出处
期刊:American Journal of Neuroradiology [American Society of Neuroradiology]
卷期号:44 (6): 634-640 被引量:10
标识
DOI:10.3174/ajnr.a7865
摘要

Surgical clipping and endovascular treatment are commonly used in patients with unruptured intracranial aneurysms. We compared the safety and efficacy of the 2 treatments in a randomized trial.Clipping or endovascular treatments were randomly allocated to patients with one or more 3- to 25-mm unruptured intracranial aneurysms judged treatable both ways by participating physicians. The study hypothesized that clipping would decrease the incidence of treatment failure from 13% to 4%, a composite primary outcome defined as failure of aneurysm occlusion, intracranial hemorrhage during follow-up, or residual aneurysms at 1 year, as adjudicated by a core lab. Safety outcomes included new neurologic deficits following treatment, hospitalization of >5 days, and overall morbidity and mortality (mRS > 2) at 1 year. There was no blinding.Two hundred ninety-one patients were enrolled from 2010 to 2020 in 7 centers. The 1-year primary outcome, ascertainable in 290/291 (99%) patients, was reached in 13/142 (9%; 95% CI, 5%-15%) patients allocated to surgery and in 28/148 (19%; 95% CI, 13%-26%) patients allocated to endovascular treatments (relative risk: 2.07; 95% CI, 1.12-3.83; P = .021). Morbidity and mortality (mRS >2) at 1 year occurred in 3/143 and 3/148 (2%; 95% CI, 1%-6%) patients allocated to surgery and endovascular treatments, respectively. Neurologic deficits (32/143, 22%; 95% CI, 16%-30% versus 19/148, 12%; 95% CI, 8%-19%; relative risk: 1.74; 95% CI, 1.04-2.92; P = .04) and hospitalizations beyond 5 days (69/143, 48%; 95% CI, 40%-56% versus 12/148, 8%; 95% CI, 5%-14%; relative risk: 0.18; 95% CI, 0.11-0.31; P < .001) were more frequent after surgery.Surgical clipping is more effective than endovascular treatment of unruptured intracranial aneurysms in terms of the frequency of the primary outcome of treatment failure. Results were mainly driven by angiographic results at 1 year.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
温暖友易发布了新的文献求助10
2秒前
2秒前
2秒前
3秒前
5秒前
5秒前
乐乐应助zsz2016采纳,获得10
7秒前
babao关注了科研通微信公众号
7秒前
hyhyhyhy发布了新的文献求助10
7秒前
活泼奇异果完成签到,获得积分20
8秒前
句vvvvi发布了新的文献求助10
9秒前
10秒前
10秒前
Orange应助无私的睫毛采纳,获得10
10秒前
WTaMi发布了新的文献求助10
11秒前
完美世界应助科研小垃圾采纳,获得10
12秒前
13秒前
兔狲完成签到 ,获得积分10
13秒前
华仔应助Phoo采纳,获得10
18秒前
Clivia发布了新的文献求助10
19秒前
句vvvvi完成签到,获得积分10
20秒前
babao发布了新的文献求助10
20秒前
21秒前
彩虹先生应助YY采纳,获得60
21秒前
Peyton Why发布了新的文献求助10
22秒前
25秒前
2426132085发布了新的文献求助10
26秒前
Peyton Why完成签到,获得积分10
27秒前
28秒前
李健应助Clivia采纳,获得10
29秒前
丘比特应助无私的睫毛采纳,获得10
30秒前
30秒前
31秒前
郭de钢发布了新的文献求助20
33秒前
33秒前
云野完成签到,获得积分10
35秒前
开朗大雁关注了科研通微信公众号
36秒前
镜子发布了新的文献求助10
36秒前
37秒前
高分求助中
Hydrological Drought Processes and Estimation Methods for Streamflow and Groundwater 1000
Teaching Social and Emotional Learning in Physical Education 900
Gymnastik für die Jugend 600
Chinese-English Translation Lexicon Version 3.0 500
Electronic Structure Calculations and Structure-Property Relationships on Aromatic Nitro Compounds 500
マンネンタケ科植物由来メロテルペノイド類の網羅的全合成/Collective Synthesis of Meroterpenoids Derived from Ganoderma Family 500
[Lambert-Eaton syndrome without calcium channel autoantibodies] 440
热门求助领域 (近24小时)
化学 材料科学 医学 生物 有机化学 工程类 生物化学 纳米技术 物理 内科学 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 电极 光电子学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 2383988
求助须知:如何正确求助?哪些是违规求助? 2090949
关于积分的说明 5256669
捐赠科研通 1817903
什么是DOI,文献DOI怎么找? 906832
版权声明 559045
科研通“疑难数据库(出版商)”最低求助积分说明 484116